Login
- Title:
Adjuvant Antibody Therapy with Trastuzumab in Early Breast Cancer
- Author(s):
- Untch, Michael; Scharl, Anton; Jackisch, Christian; Thomssen, Christoph; Nitz, Ulrike; Minckwitz, Gunter von; Harbeck, Nadia
- Abstract:
- Immunotherapy with the monoclonal antibody trastuzumab is a well established cornerstone of an individualized treatment strategy for women with HER2/neu-overexpressing breast cancer. Based on the reported data of clinical studies comprising more than 14,000 women, trastuzumab was approved throughout the European Union in May 2006 for adjuvant therapy in patients with early-stage HER2/neu-overexpressing breast cancer.
- Journal title:
- Breast Care
- Year:
- 2006
- Journal volume:
- 1
- Journal issue:
- 4
- Pages contribution:
- 252--255
- Fulltext / DOI:
- doi:10.1159/000094891
- Publisher:
- S. Karger GmbH
- Publisher address:
- Freiburg, Germany
- Print-ISSN:
- 1661-3805
- E-ISSN:
- 1661-3805
- Notes:
- Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich. This publication is with permission of the rights owner freely accessible due to an Alliance licence and a national licence (funded by the DFG, German Research Foundation) respectively.
BibTeX
Occurrences: